91503-67-2

Basic information

• Product Name: 3-Cyclohexene-1-carboxylic acid, phenylmethyl ester
• Synonyms: BENZYL CYCLOHEX-3-ENECARBOXYLATE;3-cyclohexene-1-carboxylic acid benzyl ester;Benzyl (+-)-3-cyclohexene-1-carboxylate;3-Cyclohexene-1-carboxylic acid,phenylmethyl ester
• CAS NO: 91503-67-2
• Molecular Formula: C14H16O2
• Molecular Weight: 216.28
• Mol File: 91503-67-2.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 3-Cyclohexene-1-carboxylic acid, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Cyclohexene-1-carboxylic acid, phenylmethyl ester(91503-67-2)
• EPA Substance Registry System: 3-Cyclohexene-1-carboxylic acid, phenylmethyl ester(91503-67-2)

Safety Data

• Hazardous Substances Data: 91503-67-2(Hazardous Substances Data)

Upstream product

• 4771-80-6 1,2,5,6-tetrahydrobenzoic acid 
• 100-51-6 benzyl alcohol 
• 123762-06-1 benzyl 4-hydroxycyclohexane-1-carboxylate 
• 100-39-0 benzyl bromide 
• 287972-60-5 4-hydroxy-bicyclo[3.1.0]hexane-1-carboxylic acid benzyl ester 
• 216106-48-8 4-oxo-bicyclo[3.1.0]hexane-1-carboxylic acid benzyl ester 
• 110745-68-1 3-Oxo-cyclopent-1-enecarboxylic acid benzyl ester 
• 226923-29-1 4-(imidazole-1-carbothioyloxy)-bicyclo[3.1.0]hexane-1-carboxylic acid benzyl ester 

Downstream Products

• 123762-08-3 3-oxocyclohexanecarboxylic acid benzyl ester 
• 62596-26-3 benzyl 4-oxocyclohexane-1-carboxylate 
• 123762-07-2 benzyl 3-hydroxycyclohexanecarboxylate 
• 123762-06-1 benzyl 4-hydroxycyclohexane-1-carboxylate 
• 75228-33-0 benzyl 3,4-epoxycyclohexanecarboxylate 

Relevant articles and documents

BICYCLIC NITROGENATED HETEROCYCLIC COMPOUND

The present invention provides: a novel use of a specific bicyclic nitrogen-containing heterocyclic compound as a PDE7 inhibitor; a novel bicyclic nitrogen-containing heterocyclic compound having a PDE7 inhibitory effect, a method for producing the compound, a use of the compound, and a pharmaceutical composition containing the PDE7 inhibitor or the compound; and others. More specifically, the present invention provides a PDE7 inhibitor containing the compound represented by the formula (I): [wherein the symbols have the same meanings as those described in the description] or a pharmaceutically acceptable salt thereof as an active ingredient.

Stereoselective synthesis and biological evaluation of 3,4-diaminocyclohexanecarboxylic acid derivatives as factor Xa inhibitors

There have been few reports on synthetic methods for cis-1,2-diaminocyclohexane bearing a third ring substituent. Starting from 3-cyclohexenecarboxylic acid, we developed efficient methods for synthesizing the 3,4-diaminocyclohexanecarboxylic acid derivat

DIAMINE DERIVATIVES

A compound represented by the general formula (1):Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4 wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.